Hazelden Betty Ford Foundation Beaverton

Hazelden Betty Ford Foundation Beaverton

Services:
Facility Smoking Policy
• Smoking permitted in designated area

Pharmacotherapies

• Buprenorphine (extended-release, injectable)
• Naltrexone (extended-release, injectable)
• Non-nicotine smoking/tobacco cessation
• Medication for mental disorders
• Buprenorphine with naloxone
• Naltrexone (oral)
• Nicotine replacement
• Acamprosate (Campral®)
• Disulfiram
• Buprenorphine sub-dermal implant

Special Programs/Groups Offered

• Clients with co-occurring mental and substance use disorders
• Clients who have experienced trauma

License/Certification/Accreditation

• State Substance use treatment agency
• State mental health department
• The Joint Commission

Assessment/Pre-treatment

• Comprehensive mental health assessment
• Comprehensive substance use assessment
• Screening for substance use
• Screening for mental disorders
• Interim services for clients
• Outreach to persons in the community
• Screening for tobacco use

Age Groups Accepted

• Young Adults
• Adults

Facility Vaping Policy

• Vaping permitted in designated area

Transitional Services

• Outcome follow-up after discharge
• Aftercare/continuing care
• Naloxone and overdose education
• Discharge Planning

Type of Opioid Treatment

• Accepts clients using MAT but prescribed elsewhere
• Relapse prevention with naltrexone
• Prescribes buprenorphine
• Prescribes naltrexone
• Buprenorphine maintenance
• Maintenance service with medically supervised withdrawal after stabilization

Type of Care

• Detoxification
• Substance use treatment

Education and Counseling Services

• Group counseling
• Marital/couples counseling
• Hepatitis education, counseling, or support
• Individual counseling
• HIV or AIDS education, counseling, or support
• Smoking/vaping/tobacco cessation counseling
• Family counseling
• Substance use disorder education
• Health education services other than HIV/AIDS or hepatitis

External Source of Medications Used for Alcohol Use Disorder Treatment

• In-network prescribing entity
• Other contracted prescribing entity
• No formal relationship with prescribing entity

External Opioid Medications Source

• Other contracted prescribing entity
• In-network prescribing entity

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment

Recovery Support Services

• Recovery coach
• Housing services
• Assistance with obtaining social services
• Mentoring/peer support

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Intensive outpatient treatment
• Outpatient detoxification
• Outpatient methadone/buprenorphine or naltrexone treatment
• Outpatient day treatment or partial hospitalization
• Outpatient
• Regular outpatient treatment

Exclusive Services

• Specially designed program for DUI/DWI clients

Ancillary Services

• Case management service
• Mental health services
• Social skills development

Gender Accepted

• Female
• Male

Facility Operation (e.g., Private, Public)

• Private non-profit organization

Treatment Approaches

• 12-step facilitation
• Contingency management/motivational incentives
• Matrix Model
• Substance use disorder counseling
• Brief intervention
• Telemedicine/telehealth therapy
• Trauma-related counseling
• Relapse prevention
• Motivational interviewing
• Cognitive behavioral therapy

Testing

• Breathalyzer or blood alcohol testing
• Drug and alcohol oral fluid testing
• Drug or alcohol urine screening
• Testing for Hepatitis C (HCV)
• TB screening
• Testing for Hepatitis B (HBV)
• STD testing

Payment/Insurance/Funding Accepted

• Federal military insurance (e.g., TRICARE)
• Private health insurance
• Cash or self-payment